GHP / 2020 International Life Sciences Awards 17 , Best Boutique Life Science Strategy& Investments Consultancy - Europe Biotechnology and, more generally, life-science investments have significantly grown in popularity in recent years, but finding the path that will lead to financial success is not always easy. DrMarcus A. Koch of MAKVIA is a successful strategist and advisor in the field, ensuring his clients make informed and profound decisions that trulymake an impact. We take a closer look at Dr. Koch and his firm in the light of its award-winning success to find out more. Investment in life sciences is no easy job. It requires a great deal of skill and experience in order to achieve the exceptional results that so many investors wish for. Those who successfully consult on life-science investments, should ideally bring together experience in strategy development, the commercialization of health technologies as well as investment evaluation. Fortunately, Dr Koch has all three in spades. For the last fifteen years, Dr Koch has worked tirelessly across the different sectors that form the basis of his business success. He brings a unique combination of different factors to clients based on his interesting and varied career. Dr Koch, educated in pharmaceutical sciences, medicinal chemistry, market access, health economics, and finance, started his career as a top management consultant at Bain & Company and Booz & Company, advising life science clients on strategy across the value chain. Subsequently, Dr Koch spent seven years at Amgen gaining hands-on biopharmaceutical industry experience in strategic planning, marketing, sales and medical affairs at corporate and affiliate level. When combined with three years of investment banking as a senior pharma equity research analyst in a top ranked team at UBS, it’s clear to see why clients turn to Dr Koch for their strategy and investment needs in the field of life sciences. Unlike many consultants, who often specialise in a specific area, Dr Koch can provide a truly holistic perspective on proceedings. He essentially leverages all pillars of his diverse background to ensure that his clients get thorough and trustworthy advice that helps them achieve their ambitious goals. Of course, collaboration is key, and as a boutique firm, he can afford to take the time to truly get to know what his clients want and offer bespoke solutions to match their specific needs and requirements. Making a successful investment strategy is not simply a matter of experience, however, and Dr Koch has developed various frameworks and methodologies for strategy development, pharmaceutical forecasting as well as investment identification and management that play a major role in his client work and continued success. Finding the right person to trust with investment advice is never easy, but Dr Koch has committed to a style that is frank and to the point. He promises to tell clients the information that they need to hear most, whether or not it is something they want to hear. This promise and commitment are the foundation of everything that MAKVIA does. A broad base of knowledge and a holistic approach have allowed Dr Koch to achieve truly remarkable things when it comes to advising others on strategy and investments in life sciences. Few could argue with his stunning results, built on a solid scientific basis and a rigorous dedication to excellence Sep20103 MAKVIA Dr. Marcus A. Koch Contact Details: Company: MAKVIA Dr. Marcus A. Koch Website: www.makvia.com and making an impact at all levels. His success makes him a worthy winner in this year’s International Life Sciences Awards from GHP.